Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...

EIA’s latest monthly “Electric Power Monthly” report (with data through October 31, 2025), once again confirms that solar is the fastest-growing source of US electricity. In October alone, electrical ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Google has updated its JavaScript SEO basics documentation to clarify how Google’s crawler handles noindex tags in pages that use JavaScript. In short, if “you do want the page indexed, don’t use a ...

Use ChatGPT to generate validated startup ideas quickly. Leverage your experience, analyze market gaps and customer complaints, cross-pollinate solutions between industries, follow money flow trends, ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

Google is ramping up its efforts to compete with OpenAI with the debut of Flow, a new video-generating AI model designed for filmmakers. (Disclosure: Ziff Davis, ZDNET's parent company, filed an April ...

Grok, the chatbot from Elon Musk’s AI company, xAI, has gained a canvas-like feature for editing and creating documents and basic apps. Called Grok Studio, the feature was announced on X late Tuesday.

It may seem simple, but this full ChatGPT-generated wine glass represents a major leap forward in AI capabilities. Sometimes the most significant technological advancements are revealed in the most ...